|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Human PLA2G7 ORF mammalian expression plasmid, C-GFPSpark tag||HG10848-ACG|
|Human PLA2G7 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||HG10848-ACR|
|Human PLA2G7 ORF mammalian expression plasmid, C-Flag tag||HG10848-CF|
|Human PLA2G7 ORF mammalian expression plasmid, C-His tag||HG10848-CH|
|Human PLA2G7 ORF mammalian expression plasmid, C-Myc tag||HG10848-CM|
|Human PLA2G7 ORF mammalian expression plasmid, C-HA tag||HG10848-CY|
|Human PLA2G7 Gene cDNA clone plasmid||HG10848-M|
|Human PLA2G7 ORF mammalian expression plasmid, N-Flag tag||HG10848-NF|
|Human PLA2G7 ORF mammalian expression plasmid, N-His tag||HG10848-NH|
|Human PLA2G7 ORF mammalian expression plasmid, N-Myc tag||HG10848-NM|
|Human PLA2G7 ORF mammalian expression plasmid, N-HA tag||HG10848-NY|
|Human PLA2G7 natural ORF mammalian expression plasmid||HG10848-UT|
|Learn more about expression Vectors|
Platelet-activating factor acetylhydrolase, also known as 1-alkyl-2-acetylglycerophosphocholine esterase, 2-acetyl-1-alkylglycero-phosphocholine esterase, Group-VIIA phospholipase A2, LDL-associated phospholipase A2, PAF 2-acylhydrolase, PLA2G7 and PAFAH, is secreted protein which belongs to the AB hydrolase superfamily and Lipase family. PLA2G7 / PAFAH modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. It has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids. PLA2G7 / PAFAH is a potent pro- and anti-inflammatory molecule that has been implicated in multiple inflammatory disease processes, including cardiovascular disease. PLA2G7 also represents an important, potentially functional candidate in the pathophysiology of coronary artery disease (CAD). Defects in PLA2G7 are the cause of platelet-activating factor acetylhydrolase deficiency (PLA2G7 deficiency). It is a trait which is present in 27% of Japanese. It could have a significant physiologic effect in the presence of inflammatory bodily responses.